Amplifon S.p.A Other Non-Current Liabilities 2019-2024 | AMFPF
Amplifon S.p.A other non-current liabilities from 2019 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Amplifon S.p.A other non-current liabilities for the quarter ending September 30, 2024 were $0.286B, a 11.2% increase year-over-year.
- Amplifon S.p.A other non-current liabilities for 2024 were $0.252B, a 5.99% increase from 2023.
- Amplifon S.p.A other non-current liabilities for 2023 were $0.238B, a 10.44% increase from 2022.
- Amplifon S.p.A other non-current liabilities for 2022 were $0.215B, a 21.8% decline from 2021.
| Amplifon S.p.A Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $252 |
| 2023 | $238 |
| 2022 | $215 |
| 2021 | $275 |
| 2020 | $289 |
| 2019 | $266 |
| 2018 | $251 |
| Amplifon S.p.A Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-03-31 | $286 |
| 2023-03-31 | $223 |
| 2022-03-31 | $253 |
| 2021-03-31 | $308 |
| 2020-03-31 | $258 |
| 2019-03-31 | $250 |
| 2018-12-31 | $251 |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.378B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.405B | 26.15 |
| CVS Health (CVS) | United States | $80.076B | 9.95 |
| Elevance Health (ELV) | United States | $68.334B | 9.16 |
| Cencora (COR) | United States | $57.058B | 19.85 |
| DiDi Global (DIDIY) | China | $27.204B | 28.90 |
| Labcorp Holdings (LH) | United States | $20.694B | 16.78 |
| Natera (NTRA) | United States | $19.578B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.107B | 0.00 |
| Solventum (SOLV) | United States | $12.779B | 13.53 |
| ICON (ICLR) | Ireland | $11.862B | 11.03 |
| Revvity (RVTY) | United States | $11.266B | 19.39 |
| Viatris (VTRS) | United States | $10.880B | 3.74 |
| Medpace Holdings (MEDP) | United States | $9.173B | 24.36 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.822B | 0.00 |
| HealthEquity (HQY) | United States | $8.658B | 37.92 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.959B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.696B | 15.08 |
| Bausch + Lomb (BLCO) | Canada | $5.017B | 29.54 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.899B | 37.70 |
| Alignment Healthcare (ALHC) | United States | $2.602B | 0.00 |
| Concentras Parent (CON) | United States | $2.533B | 14.64 |
| Organon (OGN) | United States | $2.506B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.295B | 88.37 |
| Progyny (PGNY) | United States | $1.972B | 43.42 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Premier (PINC) | United States | $1.735B | 13.17 |
| GoodRx Holdings (GDRX) | United States | $1.689B | 33.79 |
| Ardent Health (ARDT) | United States | $1.656B | 7.06 |
| Teladoc Health (TDOC) | United States | $1.410B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.103B | 8.39 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.898B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.779B | 7.29 |
| CareDx (CDNA) | United States | $0.658B | 10.27 |
| Nutex Health (NUTX) | United States | $0.615B | 9.32 |
| Embecta (EMBC) | United States | $0.576B | 3.88 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.569B | 0.00 |
| So-Young (SY) | China | $0.507B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.68 |
| Omada Health (OMDA) | $0.456B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.315B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.113B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.052B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |